Congenital malformations among infants born to women receiving montelukast, inhaled corticosteroids, and other asthma medications Linda M. Nelsen, MHS, Kristine E. Shields, MSN, MPH, Michael L. Cunningham, MD, PhD, Joan M. Stoler, MD, Michael J. Bamshad, MD, P. Mona Eng, ScD, Steven S. Smugar, MD, A. Lawrence Gould, PhD, George Philip, MD Journal of Allergy and Clinical Immunology Volume 129, Issue 1, Pages 251-254.e6 (January 2012) DOI: 10.1016/j.jaci.2011.09.003 Copyright © 2011 American Academy of Allergy, Asthma & Immunology Terms and Conditions
Fig E1 Mother-infant cohort identification.∗Randomly selected. NA, Not applicable (patients in the Asthma Diagnosis and Reference cohorts did not have asthma medication exposures, and thus had no trimester exposure classification). Journal of Allergy and Clinical Immunology 2012 129, 251-254.e6DOI: (10.1016/j.jaci.2011.09.003) Copyright © 2011 American Academy of Allergy, Asthma & Immunology Terms and Conditions
Fig E2 Flowchart of claims profile review, medical record abstraction, and medical record review and adjudication. Journal of Allergy and Clinical Immunology 2012 129, 251-254.e6DOI: (10.1016/j.jaci.2011.09.003) Copyright © 2011 American Academy of Allergy, Asthma & Immunology Terms and Conditions